Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study

Journal of Medical Virology

Volumn 89, Issue 3, 2017, Pages 535-541

  Wu, Zeni ^a   Qin, Yu ^a,b   Yu, Lulu ^a   Lin, Chunqing ^a   Wang, Hong ^a   Cui, Jianfeng ^a   Liu, Bin ^a   Liao, Yiqun ^c   Warren, De'Andre ^a,d   Zhang, Xun ^a   Chen, Wen ^a  

^a CANCER HOSPITAL   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

cervical cancer; human papillomavirus (HPV); viral load

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ARTICLE; BETA GLOBIN GENE; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PRECANCER; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS LOAD; WART VIRUS; ADULT; CANCER GRADING; CLASSIFICATION; CLINICAL TRIAL; COMPLICATION; CYTOCHEMISTRY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HISTOCYTOCHEMISTRY; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 85001875244     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24645     Document Type: Article

References (35)

1. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, Johansson B. 2005. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92:2195–2200.
2. Boulet GA, Benoy IH, Depuydt CE, Horvath CA, Aerts M, Hens N, Vereecken AJ, Bogers JJ. 2009. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: Biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting? Cancer Epidemiol Biomarkers Prev 18:2992–2999.
3. Carcopino X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, Tamalet C. 2006. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 78:1131–1140.
4. Carcopino X, Henry M, Mancini J, Giusiano S, Boubli L, Olive D, Tamalet C. 2012. Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy. J Med Virol 84:306–313.
5. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M. 2007. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 106:549–557.
6. Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C. 2003. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 106:396–403.
7. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056.
8. Doorbar J. 2005. The papillomavirus life cycle. J Clin Virol 32:S7–S15.
9. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA. 2012. The biology and life-cycle of human papillomaviruses. Vaccine 30:F55–F70.
10. Flores R, Papenfuss M, Klimecki WT, Giuliano AR. 2006. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 118:1187–1193.
11. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W. 2007. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 20:256–266.
12. Hesselink AT, Berkhof J, Heideman DA, Bulkmans NW, van Tellingen JE, Meijer CJ, Snijders PJ. 2009. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int J Cancer 124:381–386.
13. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet 355:2189–2193.
14. Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD. 2006. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 66:10112–10119.
15. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS. 2004. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 92:225–231.
16. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228–229.
17. Lowe B, O'Neil D, Loeffert D, Nazarenko I. 2011. Distribution of Human papillomavirus load in clinical specimens. J Virol Methods 173:150–152.
18. Manawapat A, Stubenrauch F, Russ R, Munk C, Kjaer SK, Iftner T. 2012. Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: Results from a population based long-term prospective cohort study. Am J Cancer Res 2:192–203.
19. McCluggage WG. 2013. New developments in endocervical glandular lesions. Histopathology 62:138–160.
20. Moberg M, Gustavsson I, Gyllensten U. 2003. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41:3221–3228.
21. Pan QJ, Hu SY, Zhang X, Ci PW, Zhang WH, Guo HQ, Cao J, Zhao FH, Lytwyn A, Qiao YL. 2013. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China. Cancer Cytopathol 121:473–482.
22. Pett M, Coleman N. 2007. Integration of high-risk human papillomavirus: A key event in cervical carcinogenesis? J Pathol 212:356–367.
23. Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL. 2008. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 46:3678–3685.
24. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M. 2013. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 51:1458–1464.
25. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. 2002. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 76:41–47.
26. Sundstrom K, Ploner A, Dahlstrom LA, Palmgren J, Dillner J, Adami HO, Ylitalo N, Sparen P. 2013. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer. Cancer Epidemiol Biomarkers Prev 22:150–158.
27. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37:1030–1034.
28. Tabora N, Ferrera A, Bakkers JM, Massuger LF, Melchers WJ. 2008. High HPV 16 viral load is associated with increased cervical dysplasia in Honduran women. Am J Trop Med Hyg 78:843–846.
29. Tjalma WA, Depuydt CE. 2013. Cervical cancer screening: Which HPV test should be used-L1 or E6/E7? Eur J Obstet Gynecol Reprod Biol 170:45–46.
30. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, van den Brule AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance. Int J Cancer 98:590–595.
31. Winer RL, Xi LF, Shen Z, Stern JE, Newman L, Feng Q, Hughes JP, Koutsky LA. 2014. Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women. Int J Cancer 134:1889–1898.
32. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264–269.
33. Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M. 2011. Viral load in the natural history of human papillomavirus type 16 infection: A nested case-control study. J Infect Dis 203:1425–1433.
34. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, Santini D, Musiani M. 2001. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 54:377–380.
35. Zhao FH, Jeronimo J, Qiao YL, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE. 2013. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) 6:938–948.